Isabelle Pellegrin

3.7k total citations
70 papers, 2.1k citations indexed

About

Isabelle Pellegrin is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Isabelle Pellegrin has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Infectious Diseases, 44 papers in Virology and 20 papers in Epidemiology. Recurrent topics in Isabelle Pellegrin's work include HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (35 papers) and HIV/AIDS Research and Interventions (28 papers). Isabelle Pellegrin is often cited by papers focused on HIV Research and Treatment (44 papers), HIV/AIDS drug development and treatment (35 papers) and HIV/AIDS Research and Interventions (28 papers). Isabelle Pellegrin collaborates with scholars based in France, United States and Belize. Isabelle Pellegrin's co-authors include Hervé Fleury, Jean‐Luc Pellegrin, A.M. Aubertin, A. Kirn, Christiane Moog, M Harzic, D. Neau, Geneviève Chêne, Marie‐Claude Saux and Isabelle Garrigue and has published in prestigious journals such as PLoS ONE, Hepatology and Neurology.

In The Last Decade

Isabelle Pellegrin

69 papers receiving 2.1k citations

Peers

Isabelle Pellegrin
Isabelle Pellegrin
Citations per year, relative to Isabelle Pellegrin Isabelle Pellegrin (= 1×) peers Benoît Trottier

Countries citing papers authored by Isabelle Pellegrin

Since Specialization
Citations

This map shows the geographic impact of Isabelle Pellegrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Pellegrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Pellegrin more than expected).

Fields of papers citing papers by Isabelle Pellegrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Pellegrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Pellegrin. The network helps show where Isabelle Pellegrin may publish in the future.

Co-authorship network of co-authors of Isabelle Pellegrin

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Pellegrin. A scholar is included among the top collaborators of Isabelle Pellegrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Pellegrin. Isabelle Pellegrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Autaa, Gaëlle, Daniil Korenkov, Josine van Beek, et al.. (2025). Re-evaluating CD57 as a marker of T cell senescence: implications for immune ageing and differentiation. Immunity & Ageing. 22(1). 47–47.
2.
Autaa, Gaëlle, Laura Papagno, Daniil Korenkov, et al.. (2025). Aging and inflammation limit the induction of SARS-CoV-2–specific CD8+ T cell responses in severe COVID-19. JCI Insight. 10(4). 1 indexed citations
3.
Grasset, Leslie, Vincent Bouteloup, Federica Cacciamani, et al.. (2024). Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort. Neurology. 102(9). e209307–e209307. 10 indexed citations
4.
Bouteloup, Vincent, Isabelle Pellegrin, Bruno Dubois, et al.. (2024). Explaining the Variability of Alzheimer Disease Fluid Biomarker Concentrations in Memory Clinic Patients Without Dementia. Neurology. 102(8). e209219–e209219. 11 indexed citations
5.
Raymond‐Letron, Isabelle, et al.. (2023). Validation of ELISAs for Isoflavones and Enterolactone for Phytoestrogen Intake Assessment in the French Population. Nutrients. 15(4). 967–967. 5 indexed citations
6.
Gensous, Noémie, Patrick Blanco, Estibaliz Lazaro, et al.. (2022). Pilot study on accelerated aging in lupus using epigenetic biomarkers of age. Lupus. 32(1). 129–135. 2 indexed citations
7.
Kaminski, Hannah, Nassim Kamar, Olivier Thaunat, et al.. (2022). Incidence of cytomegalovirus infection in seropositive kidney transplant recipients treated with everolimus: A randomized, open-label, multicenter phase 4 trial. American Journal of Transplantation. 22(5). 1430–1441. 11 indexed citations
8.
Duffau, P., Fabrice Bonnet, Charles Cazanave, et al.. (2018). Multimorbidity, age-related comorbidities and mortality. AIDS. 32(12). 1651–1660. 35 indexed citations
9.
Duffau, P., Frédéric‐Antoine Dauchy, Claire Rigothier, et al.. (2017). Activation, senescence and inflammation markers in HIV patients. AIDS. 31(8). 1119–1128. 7 indexed citations
10.
Wittkop, Linda, Daniel Commenges, Isabelle Pellegrin, et al.. (2008). Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapy. BMC Medical Research Methodology. 8(1). 68–68. 4 indexed citations
11.
Pellegrin, Isabelle, Anne Caumont, Isabelle Garrigue, et al.. (2002). Predictive Value of Provirus Load and DNA Human Immunodeficiency Virus Genotype for Successful Abacavir‐Based Simplified Therapy. The Journal of Infectious Diseases. 187(1). 38–46. 40 indexed citations
12.
Savès, Marianne, Philippe Morlat, Geneviève Chêne, et al.. (2001). Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy. Clinical Immunology. 99(3). 347–352. 25 indexed citations
13.
Pellegrin, Isabelle, et al.. (2001). Comparison of capillary electrophoresis sequencing with the new CEQ 2000 DNA Analysis System to conventional gel based systems for HIV drug resistance analysis. Journal of Virological Methods. 98(1). 9–16. 24 indexed citations
15.
Burgard, Marianne, Jacques Izopet, Catherine Tamalet, et al.. (2000). HIV RNA and HIV DNA in Peripheral Blood Mononuclear Cells Are Consistent Markers for Estimating Viral Load in Patients Undergoing Long-Term Potent Treatment. AIDS Research and Human Retroviruses. 16(18). 1939–1947. 41 indexed citations
16.
Pellegrin, Isabelle, Isabelle Garrigue, Didier Koumavi Ekouévi, et al.. (2000). New Molecular Assays to Predict Occurrence of Cytomegalovirus Disease in Renal Transplant Recipients. The Journal of Infectious Diseases. 182(1). 36–42. 30 indexed citations
17.
Chêne, Geneviève, Christine Binquet, Jean‐François Moreau, et al.. (1998). Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. AIDS. 12(17). 2313–2320. 63 indexed citations
18.
Lafon, Marie‐Edith, H. Dutronc, Véronique Dubois, et al.. (1998). JC Virus Remains Latent in Peripheral Blood B Lymphocytes but Replicates Actively in Urine from AIDS Patients. The Journal of Infectious Diseases. 177(6). 1502–1505. 37 indexed citations
19.
Pellegrin, Isabelle, et al.. (1996). Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages. Journal of Antimicrobial Chemotherapy. 37(3). 501–510. 7 indexed citations
20.
Constans, J., Jean‐Luc Pellegrin, E. Peuchant, et al.. (1994). Plasma lipids in HIV‐infected patients: a prospective study in 95 patients. European Journal of Clinical Investigation. 24(6). 416–420. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026